Why drug patent protection needs to be extended

imgresU.S. regulators and the drug industry want to extend by two months the deadline for the Food and Drug Administration to approve or reject new drugs.  The FDA said it would need an extra 60-day “filing date” before the clock starts ticking on its 10-month deadline to review new drugs, or six months for a priority review.  This means even less time on the market to recoup costs and is one of the reasons why new drug prices are going to continue to climb. Continue reading

It’s not about online health information, it’s what consumers do with that information

There is a lot, and I mean a lot, of health information on the Internet.  Unfortunately there is also a lot of bad health information on the Internet and consumers have to pretty much figure out for themselves which sites offer credible and good health information, that they can understand, and which ones are full of garbage.  What we should be worried about however is not all the health information that’s out there but what decisions consumers are making with information in hand. Continue reading